# US 2018/0021221 A1 · Oral Delivery Device and Methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021221 A1
- Document ID: US20180021221A1
- Status: Published application
- Kind: A1
- Application number: 15/645,810
- Filed: 2017-07-10
- Published: 2018-01-25
- Earliest claimed: 2016-07-25
- Assignees: Zeteo Biomedical LLC
- Applicants: Zeteo Biomedical LLC
- Inventors: Timothy Sullivan; Jeff Gjertsen
- Web page: https://patentgrep.com/patent/US20180021221A1

## CPC

- A61J 7/0053: {Syringes, pipettes or oral dispensers}
- A61J 7/0007: {Pill breaking or crushing devices}
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE

## Abstract

Devices for delivery of fluid compositions include a delivery device including an internally pierced blister in which the device includes a plunger configured to crush the blister and deliver the contents in a lateral direction with respect to the motion of a dispensing button. Certain devices are configured for oral delivery.

## Claims

### Claim 1

A device for delivery of a fluid composition, said device comprising:
a housing comprising a front face, a first side, a second side and a rear face, and a top, forming an interior volume;
a button comprising a first side, a second side, a first end contained within the housing and a second end extending out of the housing at an end opposite the top;
wherein the button comprises recess adapted to mechanically interact with said button, a first tab, and a second tab;
a delivery mechanism disposed in the interior volume of the housing; and
a nozzle port disposed in the front face of the housing and providing a liquid communication channel into the interior volume;
wherein the delivery mechanism comprises:
a plunger comprising a lower section adapted to be in mechanical connection to the button, wherein the lower section comprises a first arcuate surface;
an upper section comprising a cavity disposed adjacent the nozzle port and adapted to contain a crushable dosage form; and
a ram member adjacent the cavity and comprising a second arcuate face;
wherein said first tab and said second tab are adapted to interact with said first arcuate surface and said second arcuate surface to direct the motion of the ram in a direction other than the direction of motion of the button when activated.

### Claim 2 (depends on 1)

The device of claim 1, further comprising one or more finger rests, one disposed on said first and/or second side of the housing.

### Claim 3 (depends on 2)

The device of claim 2, wherein said one or more finger rests comprise a flange, one or more arcuate members comprising open or closed loops, one or more indentations, or one or more sets of ridges.

### Claim 4 (depends on 1)

The device of claim 1, further comprising a positioning device adapted to rest against the lower teeth of a user to direct a spray from the nozzle port into the oral cavity of the user.

### Claim 5 (depends on 1)

The device of claim 1, wherein the direction of motion of the ram is substantially lateral to the direction of motion of the button when activated.

### Claim 6 (depends on 1)

The device of claim 1, further comprising a crushable dosage form containing a fluid composition and an internal piercing device, wherein the internal piercing device comprises a nozzle disposed adjacent or within the nozzle port.

### Claim 7 (depends on 6)

The device of claim 6, in which the fluid is a liquid, powder or a reconstituted powder.

### Claim 8 (depends on 6)

The device of claim 6, wherein the fluid is a medical composition.

### Claim 9 (depends on 8)

The device of claim 8, in which the fluid is a cardiovascular drug, steroid, barbiturate, benzodiazepine, analgesic, anesthetic, sedative, anti-inflammatory, non-steroidal anti-inflammatory (NSAID), antigen, vaccine, hormone, endorphin, enkephalin, dynorphin endomorphin, cannabinoid, biosimilar, synthetic or semi-synthetic opioid or alkaloid analgesic or combinations of any thereof.

### Claim 10 (depends on 8)

The device of claim 8 in which the fluid comprises fentanyl, ketamine, a ketamine analog, esketamine, buprenorphine, naloxone, acetaminaphine, morphine, ethylmorphine, oxycodone, hydrocodone, meperidine, hydromorphone, alfentanil, remifentanil, sufentanil etorphine, opiod peptide, or a pharmaceutically acceptable, salt, derivative, prodrug, enantiomer, racemate, or isomer of any thereof.

### Claim 11 (depends on 8)

The device of claim 8, in which the fluid comprises a calcium channel blocker, a mineral, an NMDA antagonist, dextromethorphan, memantine, a cholecystokinin antagonist, proglumide, or a phosphodiesterase inhibitor.

### Claim 12

A device for delivery of a fluid composition, said device comprising:
a housing comprising a front face, a first side, a second side and a rear face, and a top, forming an interior volume;
a button comprising a first side, a second side, a first end contained within the housing and a second end extending out of the housing at an end opposite the top;
wherein the button comprises recess adapted to mechanically interact with said button, a first tab, and a second tab;
a delivery mechanism disposed in the interior volume of the housing; and
a nozzle port disposed in the front face of the housing and providing a liquid communication channel into the interior volume;
wherein the delivery mechanism comprises:
a plunger comprising a lower section adapted to be in mechanical connection to the button, wherein the lower section comprises a first arcuate surface;
an upper section comprising a cavity disposed adjacent the nozzle port and adapted to contain a crushable dosage form; and
a ram member adjacent the cavity and comprising a second arcuate face;
wherein said first tab and said second tab are adapted to interact with said first arcuate surface and said second arcuate surface respectively, effective to direct the motion of the ram in a direction other than the direction of motion of the button when activated; and
a crushable dosage form contained in the cavity and containing a fluid composition and an internal piercing device, wherein the internal piercing device comprises a nozzle disposed adjacent or within the nozzle port when activated.

### Claim 13 (depends on 12)

The device of claim 12, further comprising one or more finger rests, one disposed on said first and/or second side of the housing.

### Claim 14 (depends on 13)

The device of claim 13, wherein said one or more finger rests comprise a flange, one or more arcuate members comprising open or closed loops, one or more indentations, or one or more sets of ridges.

### Claim 15 (depends on 12)

The device of claim 12, further comprising a positioning device adapted to rest against the lower teeth of a user to direct a spray from the nozzle port into the oral cavity of the user.

### Claim 16 (depends on 12)

The device of claim 12, wherein the direction of motion of the ram is substantially lateral to the direction of motion of the button when activated.

### Claim 17 (depends on 12)

The device of claim 12, in which the fluid is a liquid, powder or a reconstituted powder.

### Claim 19 (depends on 17)

The device of claim 17, wherein the fluid is a medical composition.

### Claim 20 (depends on 17)

The device of claim 17, in which the fluid is a cardiovascular drug, steroid, barbiturate, benzodiazepine, analgesic, anesthetic, sedative, anti-inflammatory, non-steroidal anti-inflammatory (NSAID), antigen, vaccine, hormone, endorphin, enkephalin, dynorphin endomorphin, cannabinoid, biosimilar, synthetic or semi-synthetic opioid or alkaloid analgesic or combinations of any thereof.

### Claim 21 (depends on 17)

The device of claim 17 in which the fluid comprises fentanyl, ketamine, a ketamine analog, esketamine, buprenorphine, naloxone, acetaminaphine, morphine, ethylmorphine, oxycodone, hydrocodone, meperidine, hydromorphone, alfentanil, remifentanil, sufentanil etorphine, opiod peptide, or a pharmaceutically acceptable, salt, derivative, prodrug, enantiomer, racemate, or isomer of any thereof.

### Claim 22 (depends on 17)

The device of claim 17, in which the fluid comprises a calcium channel blocker, a mineral, an NMDA antagonist, dextromethorphan, memantine, a cholecystokinin antagonist, proglumide, or a phosphodiesterase inhibitor.

### Claim 23 (depends on 12)

A method of administering a drug to the oral cavity of a user comprising:
positioning a device according to claim 12 such that the nozzle port is aimed into the oral cavity of the user; and
activating the button effected to crush the dosage form and administer the fluid in a spray, stream or mist into the oral cavity of the user;
wherein the device is positioned such that a user activates the button in an upward direction and the fluid is dispensed laterally into the oral cavity.

### Claim 24 (depends on 23)

The method of claim 23, wherein the device comprises a positioning device, and wherein the positioning device is rested against the lower teeth of the user during activation of the button.

### Claim 25 (depends on 1)

A method of delivering a fluid substance to the sublingual or buccal tissue of a human or non-human animal comprising dispensing a fluid substance from the device of claim 1.
